Changes in the regional density of muscarinic-1 (M1) receptors and the effect of lisuride hydrogen maleate on these changes were studied in senescent rat brain by in vitro autoradiography. In young adult controls, M1 receptor binding was most dense in the striatum and hippocampus, followed by the cerebral cortex and amygdala. Binding to M1 receptors was markedly lower in these areas of the senescent brain compared with the young adult brain. These decreases were reversed by intraperitoneal administration of 50 μg/kg·day lisuride for 14 days. The present results indicate that the therapeutic efficacy of lisuride depends on normalization of not only monoamine systems but also acetylcholine systems.
DavisPMaloneyAJFSelective loss of central cholinergic neurons in Alzheimer's disease. Lancet1976; ii: 1403.
2.
PerryEKPerryRHBlessedGNecropsy evidence of central cholinergic deficits in senile dementia. Lancet1977; i: 189.
3.
OgawaNHiroseYNomuraMBiochemical and functional aspects of neuropeptides and their receptors in aged-rat brain. In: Recent Research on Neurotransmitter Receptors (YoshidaH ed). Amsterdam: Excerpta Medica, 1986; pp 56–68.
4.
OgawaNHabaKYoshikawaHEffects of lisuride hydrogen maleate on ischemia-induced depletion of brain acetylcholine levels in gerbils. Clin Ther1989; 11: 241–246.
5.
OgawaNMizukawaKSoraIChronic dihydroergotoxine administration increases muscarinic cholinergic receptor binding in aged-rat brain. Res Commun Chem Pathol Pharmacol1987; 57: 149–159.
6.
MizukawaKOgawaNSoraYAlterations of the muscarinic cholinergic receptor in striatum of the MPTP-induced parkinsonian model in mice: in vitro quantitative autoradiographical analysis. Neurosci Lett1987; 81: 105–110.
7.
CoyleJTPriceDLDelongMRAlzheimer's disease a disorder of cortical cholinergic innervation. Science1983; 219: 1184–1190.
8.
IchimiyaYAraiHKosakaKMorphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia. Acta Neuropathol1986; 70: 112–116.
9.
LondonEDWallerSBRelations between choline acetyltransferase and muscarinic binding in aging and Alzheimer's disease. In: Dynamics of Cholinergic Function (HaninI ed). New York: Plenum Press, 1986; pp 215–224.
10.
MashDCFlynnDDPotterLTLoss of M2-muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science1985; 228: 1115–1117.
11.
HammerRBerrieCPBirdsallNJPirenzepine distinguishes between different subclasses of muscarinic receptors. Nature1980; 283: 90–92.
12.
LuthinGRWolfeBBComparison of [3H]pirenzepine and [3H]quinuclidinylbenzylate binding to muscarinic cholinergic receptors in rat brain. J Pharmacol Exp Ther1983; 228: 648–655.
13.
HaraKIkomaYOshinoNEffects of an ergot derivative, lisuride, on the central dopaminergic system: study of behavioral pharmacology (in Japanese). Folia Pharmacol Jpn1982; 80: 1–13.
14.
HaraKIkomaYFujiedaSEffects of an ergot derivative, lisuride, on the central nervous system (in Japanese). Yakuri to Chiryou1982; 10: 3049–3073.
